Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3051 Target Snapshot

Nitric oxide synthase, inducible · SINGLE PROTEIN · Rattus norvegicus

230Compounds
28Assays
0Approved Drugs
30.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q06518. Use UniProt Q06518 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q06518 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Nitric oxide synthase, inducible as ChEMBL target CHEMBL3051, mapped to UniProt Q06518. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Nitric oxide synthase, inducible
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL3051
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q06518
Nitric oxide synthase, inducible
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Nitric oxide synthase, inducible is the right protein anchor across sources, using UniProt Q06518 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNitric oxide synthase, inducible
UniProt AccessionQ06518
Component TypeProtein
Sequence Length1147 aa

Nitric oxide synthase, inducible

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Nitric oxide synthase, inducible, mapped to UniProt Q06518. Sequence length is 1147 aa.

Mapped IDQ06518
Review nameNitric oxide synthase, inducible
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Phase III
1
Phase I
Assay Mix

Activity Type Distribution

IC5029.0
KI1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1800346 8.74 Ki 1.8 Preclinical
CHEMBL4245460 6.05 IC50 900.0 Preclinical
CHEMBL11471 5.66 IC50 2200.0 Preclinical
CHEMBL1956107 5.63 IC50 2340.0 Preclinical
CHEMBL2414836 5.01 IC50 9810.0 Preclinical
CHEMBL2414846 4.88 IC50 13200.0 Preclinical
CHEMBL2414845 4.79 IC50 16200.0 Preclinical
CHEMBL256147 4.75 IC50 18000.0 Clinical
CHEMBL233655 4.72 IC50 19000.0 Preclinical
CHEMBL227744 4.7 IC50 20000.0 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
2
5.5
1
6.0
0
6.5
0
7.0
0
7.5
0
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

28
Total Assays
28
Tested Compounds
1
Assay Types
Binding — 28 assays, 28 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 17 8 5.3
assay format 5 19 4.6
organism-based format 5 0
cell-based format 1 1 5.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine